Dr Mariana Chavez McGregor, speaks to ecancer at the Best of ASCO®️ 2024 Miami Symposium about antibody drug conjugates and how they have changed the treatment of patients with breast cancer, and how to best integrate them into treatments.

She emphasises the swift advancements in antibody-drug conjugates, predicting an increase in data on this approach in the coming years. As this method is applied earlier and new information on other drugs emerges, the process of selecting and sequencing treatments is expected to improve.